Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > RCUS Arcus Biosciences > Detailed Quotes

RCUS Arcus Biosciences

25.890
+1.370+5.59%
Close 09/27 16:00 ET
High
26.610
Open
25.040
Turnover
19.84M
Low
25.010
Pre Close
24.520
Volume
764.33K
Market Cap
1.87B
P/E(TTM)
25.89
52wk High
49.100
Shares
72.16M
P/E(Static)
36.46
52wk Low
16.740
Float Cap
1.14B
Bid/Ask %
50.00%
Historical High
49.100
Shs Float
44.14M
Volume Ratio
1.35
Historical Low
6.300
Dividend TTM
--
Div Yield TTM
--
P/B
2.50
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.73%
Amplitude
6.53%
Avg Price
25.952
Lot Size
1
Float Cap
1.14B
Bid/Ask %
50.00%
Historical High
49.100
Shs Float
44.14M
Volume Ratio
1.35
Historical Low
6.300
Dividend TTM
--
P/B
2.50
Dividend LFY
--
Turnover Ratio
1.73%
Amplitude
6.53%
Avg Price
25.952
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.
CEO: Dr. Terry Rosen, PhD
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...